# AstraZeneca

> British-Swedish pharmaceutical company

**Wikidata**: [Q731938](https://www.wikidata.org/wiki/Q731938)  
**Wikipedia**: [English](https://en.wikipedia.org/wiki/AstraZeneca)  
**Source**: https://4ort.xyz/entity/astrazeneca

## Summary
AstraZeneca is a British-Swedish multinational pharmaceutical company, formed through the 1999 merger of the Swedish company Astra and the British company Zeneca. It is a leading global biopharmaceutical entity focused on the discovery, development, and commercialization of prescription drugs, with a strong emphasis on oncology, cardiovascular, respiratory, and immunology treatments.

## Key Facts
- **Founded**: Formed in 1999 through the merger of Astra and Zeneca.
- **Predecessor Companies**: Preceded by Astra (Swedish origin) and Zeneca Group (British origin).
- **Headquarters**: Located in Cambridge, United Kingdom, with global operations.
- **Industry**: Pharmaceutical industry.
- **Products**: Develops, produces, and markets prescription drugs, including the viral vector vaccine AZD1222 (developed for COVID-19 prevention).
- **Employees**: Approximately 70,600 (as of latest data).
- **Revenue**: £24.708 billion (2022).
- **Net Profit**: £6.406 billion (2022).
- **Total Assets**: £60.056 billion (2022).
- **Stock Exchange Listings**: Listed on the London Stock Exchange, NASDAQ Stockholm, and New York Stock Exchange.
- **Ownership**: Major shareholders include BlackRock, Investor AB, Capital Group, Wellington Management, and Alexion Pharmaceuticals.
- **Key People**: Pascal Soriot (CEO).
- **Subsidiaries**: Includes Cambridge Antibody Technology, AstraZeneca (United States), and Amylin Pharmaceuticals, among others.
- **Developed Product**: AZD1222 (Oxford-AstraZeneca COVID-19 vaccine).
- **Instance Of**: Public company, business, enterprise, and pharmaceutical company.
- **Website**: [www.astrazeneca.com](http://www.astrazeneca.com)

## FAQs
**What is AstraZeneca?**
AstraZeneca is a British-Swedish pharmaceutical company that develops, produces, and markets prescription drugs. It was formed in 1999 through the merger of Astra (Sweden) and Zeneca (UK) and is now a global biopharma leader.

**When was AstraZeneca formed?**
It was officially established in 1999 through the merger of two major pharmaceutical companies, Astra and Zeneca.

**Where is AstraZeneca headquartered?**
The company is headquartered in Cambridge, United Kingdom, with a significant global presence and operations.

**What are AstraZeneca's main products?**
AstraZeneca's main products include prescription drugs in therapeutic areas such as oncology, cardiovascular, respiratory, and immunology, including the development of the AZD1222 (Oxford-AstraZeneca) COVID-19 vaccine.

**Who owns or operates AstraZeneca?**
AstraZeneca is a public company owned by shareholders including institutional investors like BlackRock, Investor AB, Capital Group, Wellington Management, and Alexion Pharmaceuticals.

**On which stock exchanges is AstraZeneca listed?**
AstraZeneca is listed on the London Stock Exchange, NASDAQ Stockholm, and the New York Stock Exchange.

**How many people work for AstraZeneca?**
As of the latest data, AstraZeneca employs approximately 70,600 people globally.

**What is AstraZeneca's revenue?**
In 2022, AstraZeneca reported a revenue of £24.708 billion, with a net profit of £6.406 billion and total assets of £60.056 billion.

**What is the significance of AZD1222?**
AZD1222, also known as the Oxford-AstraZeneca COVID-19 vaccine, is a viral vector vaccine developed by AstraZeneca for the prevention of COVID-19, playing a critical role in global pandemic response efforts.

## Why It Matters
AstraZeneca plays a pivotal role in global healthcare by developing and distributing life-saving medications. As a leader in the pharmaceutical industry, it has contributed significantly to medical advancements, particularly in oncology, immunology, and respiratory care. Its development of the Oxford-AstraZeneca COVID-19 vaccine (AZD1222) was instrumental in the global fight against the pandemic. The company's research and production capabilities have made it a cornerstone in modern medicine, impacting millions of lives. Its public company status allows for significant capital investment, enabling large-scale research and global distribution of its products.

## Notable For
- **Global Impact**: AstraZeneca is notable for its development of the Oxford-AstraZeneca COVID-19 vaccine (AZD1222), which became a critical tool in combating the global pandemic.
- **Mergers and Acquisitions**: The company has a history of strategic acquisitions, including AstraZeneca (United States) and Amylin Pharmaceuticals.
- **Innovation in Medicine**: It is recognized for its research and development in critical therapeutic areas such as oncology, cardiovascular, and respiratory diseases.
- **Global Presence**: AstraZeneca operates in key markets including the UK, US, and Sweden, with listings on major stock exchanges like the London Stock Exchange and NASDAQ Stockholm.
- **Public Company Status**: As a public company, it is subject to strict regulatory standards, ensuring transparency and investor confidence.
- **Employment and Revenue**: The company employs over 70,000 people and reported significant revenue and profit, indicating its major role in the global pharmaceutical market.
- **Leadership**: The company is led by CEO Pascal Soriot, who has guided its strategic direction and growth.
- **Historical Foundation**: Formed from the merger of Astra and Zeneca, it carries forward the legacy of two major pharmaceutical pioneers.

## Body
### History
AstraZeneca was formed in 1999 through the merger of Astra (Sweden) and Zeneca (UK). The company's origins trace back to the early 20th century with the founding of Astra in Sweden and Zeneca in the UK. The merger created a global biopharmaceutical leader with a strong focus on research and development. The company has since grown through strategic acquisitions and internal innovation, becoming a key player in the pharmaceutical industry.

### Company Structure and Operations
AstraZeneca operates as a public company, with its shares traded on the London Stock Exchange, NASDAQ Stockholm, and New York Stock Exchange. It is structured as a business and enterprise, focusing on the development and commercialization of prescription drugs. The company's operations span across major global markets, with a significant emphasis on research and development in key therapeutic areas such as oncology, cardiovascular, and respiratory diseases.

### Key Products and Developments
AstraZeneca is known for its development of the AZD1222 (Oxford-AstraZeneca) COVID-19 vaccine, which was a pivotal development in the global fight against the pandemic. The company's product portfolio includes a wide range of prescription drugs, with a strong focus on innovative treatments for serious diseases. It also develops and markets medications in various therapeutic areas, including oncology, cardiovascular, and respiratory care.

### Leadership and Governance
The company is led by CEO Pascal Soriot, who has been instrumental in guiding AstraZeneca's strategic direction and growth. The governance structure includes a board of directors and key institutional shareholders such as BlackRock, Investor AB, Capital Group, Wellington Management, and Alexion Pharmaceuticals.

### Global Presence and Operations
AstraZeneca has a significant global presence, with operations in key markets including the UK, US, and Sweden. The company's headquarters are located in Cambridge, United Kingdom, with a subsidiary base in Cambridge Biomedical Campus. It also has a strong presence in major financial markets, with listings on the London Stock Exchange, NASDAQ Stockholm, and New York Stock Exchange.

### Financials and Market Position
AstraZeneca's financial performance is robust, with reported revenues of £24.708 billion, net profit of £6.406 billion, and total assets of £60.056 billion as of 2022. The company employs approximately 70,600 people globally, reflecting its significant market position and operational scale.

### Research and Development
Research and development are at the core of AstraZeneca's operations, with a focus on innovative treatments for serious diseases. The company's commitment to R&D is evident in its substantial investments and strategic acquisitions, including Cambridge Antibody Technology and Amylin Pharmaceuticals.

### Subsidiaries and Affiliations
AstraZeneca has a diverse portfolio of subsidiaries, including AstraZeneca (United States) and Amylin Pharmaceuticals. These subsidiaries play a crucial role in the company's global operations and market reach. The company is also affiliated with key institutions and individuals, including CEO Pascal Soriot and major shareholders like BlackRock and Investor AB.

### Stock Exchange Presence
AstraZeneca is listed on the London Stock Exchange, NASDAQ Stockholm, and the New York Stock Exchange, reflecting its status as a major player in the global pharmaceutical market. Its stock exchange presence underscores its commitment to transparency and investor confidence.

### Industry Classification and Recognition
AstraZeneca is classified as a pharmaceutical company, public company, business, and enterprise. Its industry recognition is evident in its inclusion in key stock market indices such as the FTSE 100 Index, Stoxx Europe 600 Index, and Nasdaq-100.

### Contributions to Global Health
AstraZeneca's development of the Oxford-AstraZeneca COVID-19 vaccine (AZD1222) has had a significant impact on global health, particularly in the fight against the pandemic. The company's commitment to research and development has led to the creation of life-saving medications and treatments, reinforcing its role as a leader in the pharmaceutical industry.

### Future Outlook
AstraZeneca's future outlook is marked by continued innovation in drug development, strategic acquisitions, and a strong focus on addressing global health challenges. Its commitment to research and development ensures its position as a leader in the pharmaceutical industry, with a focus on delivering innovative treatments to patients worldwide.

## References

1. [annual report](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf)
2. [Source](https://www.lobbyfacts.eu/datacard/astrazeneca-plc?rid=249402638316-62)
3. [Source](https://www.astrazeneca.com/our-company/leadership.html)
4. GRID Release 2017-01-10
5. Virtual International Authority File
6. BnF authorities
7. Polygon.io
8. [Source](https://www.lanacion.com.ar/politica/alberto-fernandez-xx-nid2419369)
9. [Source](https://beta.companieshouse.gov.uk/officers/UR_GVtQ1C0JXN1sNFXzVIMUQz4I/appointments)
10. [Source](https://www.astrazeneca.ch/en/about-us/our-history.html)
11. Freebase Data Dumps. 2013
12. Google Knowledge Graph
13. Crunchbase
14. [Source](http://km.aifb.kit.edu/services/crunchbase/)
15. GRID Release 2015-12-14
16. GRID Release 2016-12-06
17. Quora
18. Aligned ISNI and Ringgold identifiers for institutions
19. [AstraZeneca: Overview | LinkedIn](https://www.linkedin.com/company/astrazeneca/)
20. [Source](https://www.astrazeneca.se/content/dam/az-se/dokument/hallbarhet/Sustainability-Report-2023.pdf)
21. [Source](https://www.astrazeneca.com/content/dam/az/Sustainability/2023/pdf/Sustainability_Data_Summary_2022.pdf)
22. [Source](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2021/pdf/AstraZeneca_AR_2021.pdf)
23. [Source](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2020/pdf/AstraZeneca_AR_2020.pdf)
24. [Source](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2019/pdf/AstraZeneca_AR_2019.pdf)
25. [Source](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-report-2018/PDF/AstraZeneca_AR_2018.pdf)
26. [Source](https://www.astrazeneca.com/content/dam/az/Investor_Relations/annual-reports-homepage/AstraZeneca_AR_2017%20(1).pdf)
27. [Source](https://www.astrazeneca.com/content/dam/az/Investor_Relations/Annual-report-2016/AZ_AR2016_Full_Report.pdf)
28. [Source](https://dn721207.ca.archive.org/0/items/astra-zeneca-ar-2024/AstraZeneca_AR_2024.pdf)
29. [Source](https://golden.com/wiki/AstraZeneca-PY54V)
30. [Working at AstraZeneca | Glassdoor](https://www.glassdoor.sg/Overview/Working-at-AstraZeneca-EI_IE9214.11,22.htm?countryRedirect=true)
31. National Library of Israel Names and Subjects Authority File
32. [ASTRAZENECA latest news & coverage](https://www.channelnewsasia.com/news/topic/astrazeneca)
33. [Astrazeneca PLC Company Culture | Comparably](https://www.comparably.com/companies/astrazeneca-plc)
34. Wikirate
35. [ITV News : The Latest Astra Zeneca News](https://www.itv.com/news/topic/astra-zeneca)